08048036315
Etibo 250mg Tablet Good Quality to UK - Liverpool | Phoenix Exim | Trusted Exporter

1. General Information

Etibo 250mg Tablet is an oncology medicine containing Lapatinib 250mg as its active ingredient. It is marketed in India by Samarth Life Sciences Pvt. Ltd. and is available as an oral tablet. Lapatinib is designed to target specific growth-signaling proteins involved in certain breast cancers.

Product: Etibo 250mg Tablet
Active ingredient: Lapatinib 250mg
Medicine class: Tyrosine kinase inhibitor
Therapeutic category: Anti-cancer / oncology medicine
Route: Oral
Typical pack: 30 tablets
Prescription: Required

2. Product Information

Etibo 250mg contains Lapatinib, a small-molecule kinase inhibitor. Each 250mg tablet provides 250mg of lapatinib equivalent. Lapatinib tablets are available in the 250mg strength and are taken orally.

The exact treatment regimen depends on the cancer subtype and the medicines being used alongside lapatinib. Therefore, the dose should not be selected or changed without the treating oncologist's advice.

3. Uses of Etibo 250mg Tablet

Etibo 250mg may be prescribed for certain forms of:

  • HER2-positive advanced breast cancer
  • HER2-positive metastatic breast cancer
  • HER2-positive metastatic breast cancer in combination with capecitabine after specified prior treatments
  • Hormone-receptor-positive, HER2-positive metastatic breast cancer in postmenopausal women when hormonal therapy is appropriate, in combination with letrozole.

The suitability of lapatinib depends on HER2 status, previous treatments, cancer progression and the overall clinical condition of the patient.

4. Benefits of Etibo 250mg Tablet

Etibo 250mg may help:

  • Slow the growth and spread of certain HER2-positive breast cancer cells.
  • Block growth signals that encourage cancer-cell multiplication.
  • Provide a targeted treatment option for eligible patients with advanced or metastatic HER2-positive breast cancer.
  • Be used as part of a combination treatment regimen with medicines such as capecitabine or letrozole when clinically appropriate.

Important: The medicine is not suitable for every breast cancer patient. Its benefit depends on the cancer's biological characteristics and the treatment plan prescribed by the oncologist.

5. Side Effects of Etibo 250mg Tablet

Possible side effects include:

  • Diarrhea
  • Nausea
  • Vomiting
  • Fatigue or weakness
  • Headache
  • Rash
  • Indigestion
  • Loss of appetite
  • Abdominal discomfort
  • Mouth sores/inflammation
  • Back or joint pain
  • Sleep difficulties
  • Hair loss
  • Skin or nail changes.

Some potentially serious reactions include liver toxicity, reduced heart function, severe diarrhea, QT prolongation, lung inflammation/pneumonitis and severe skin reactions.

6. Common Side Effects

Commonly reported effects can include:

  1. Diarrhea
  2. Nausea
  3. Vomiting
  4. Fatigue
  5. Headache
  6. Rash
  7. Loss of appetite
  8. Indigestion
  9. Weakness
  10. Abdominal discomfort
  11. Mouth sores
  12. Back or joint pain

If diarrhea becomes severe or persistent, medical advice should be obtained because dehydration and electrolyte abnormalities can occur.

7. How to Use Etibo 250mg Tablet

Take Etibo exactly as prescribed by your oncologist.

  • Swallow the tablet whole with water.
  • Do not crush, chew or break the tablet.
  • Take it once daily when prescribed.
  • Lapatinib should generally be taken at least 1 hour before or 1 hour after food.
  • Take it at approximately the same time each day.
  • Do not double the dose if you miss a dose.
  • Do not stop treatment without consulting your doctor.

The prescribed total daily dose can involve multiple 250mg tablets, so do not assume that one 250mg tablet is the complete daily dose.

8. How Etibo 250mg Works

Etibo contains lapatinib, which inhibits certain tyrosine kinase proteins associated with HER2 and EGFR signaling.

These proteins can send signals that promote cancer-cell growth and survival. By blocking these signaling pathways, lapatinib can reduce cancer-cell proliferation and signaling.

9. Safety Advice

  • Use Etibo only under specialist medical supervision.
  • Tell your doctor about liver, kidney, heart or lung problems before treatment.
  • Liver function should be monitored because lapatinib can cause potentially serious hepatotoxicity.
  • Heart function, including left ventricular ejection fraction, may need monitoring during treatment.
  • Inform your doctor about all prescription medicines, OTC medicines, vitamins and herbal products because lapatinib has clinically important drug interactions.
  • Avoid taking it during pregnancy unless specifically determined appropriate by your specialist; lapatinib can cause embryo-fetal toxicity.
  • Breastfeeding is not recommended during treatment.
  • Seek medical attention for severe diarrhea, yellowing of the skin/eyes, dark urine, unusual bleeding, breathing problems, severe rash, fainting or symptoms suggesting heart problems.
  • Store the medicine according to the product label, away from excessive heat and moisture.

10. Frequently Asked Questions (FAQs)

Q1. What is Etibo 250mg Tablet used for?
Etibo 250mg is a lapatinib-containing anti-cancer medicine used for certain HER2-positive advanced or metastatic breast cancers.

Q2. What is the active ingredient in Etibo 250mg?
The active ingredient is Lapatinib 250mg.

Q3. Is Etibo 250mg a chemotherapy medicine?
It is an anti-cancer targeted therapy, specifically a tyrosine kinase inhibitor. It works differently from traditional cytotoxic chemotherapy.

Q4. Can Etibo 250mg be taken with food?
Lapatinib should generally be taken at least one hour before or one hour after food.

Q5. Can Etibo cause diarrhea?
Yes. Diarrhea is a common adverse effect and can occasionally become severe. Persistent or severe diarrhea requires medical attention.

Q6. Can Etibo affect the liver?
Yes. Lapatinib carries an important warning for hepatotoxicity, which can occasionally be severe. Liver-function monitoring is recommended during treatment.

Q7. Can Etibo affect the heart?
Lapatinib can reduce left ventricular ejection fraction and may affect cardiac electrical activity. Your doctor may perform heart-function monitoring where appropriate.

Q8. Can Etibo 250mg be taken during pregnancy?
Lapatinib may cause fetal harm. Patients who are pregnant, planning pregnancy or could become pregnant should discuss appropriate contraception and treatment risks with their doctor.

Q9. Can Etibo be taken with other cancer medicines?
Yes. Depending on the cancer subtype and treatment history, lapatinib may be prescribed with medicines such as capecitabine or letrozole.

Q10. Is Etibo 250mg available on prescription?
Yes. It is a prescription anti-cancer medicine and should be used under qualified medical supervision.

11. Substitutes for Etibo 250mg Tablet

Substitutes should contain the same active ingredient, lapatinib, but the appropriate product depends on the patient's prescription and availability. Examples listed by Indian medicine references include:

  • Hertab 250mg Tablet
  • Libset Tablet
  • Herduo Tablet
  • Combinib 250mg Tablet
  • Lupidoc Tablet

Do not switch between brands without confirmation from the prescribing oncologist or pharmacist.

12. SEO & B2B Keywords

  • Etibo 250mg Tablet exporter from India
  • Etibo 250mg Tablet supplier from India
  • Etibo 250mg Tablet wholesale supplier
  • Etibo 250mg Tablet pharmaceutical exporter
  • Etibo 250mg Lapatinib Tablet exporter
  • Lapatinib 250mg Tablet supplier India
  • Lapatinib 250mg oncology medicine exporter
  • Etibo 250mg Tablet wholesale exporter
  • Etibo 250mg Tablet international supplier
  • Etibo 250mg Tablet medicine supplier
  • Etibo 250mg Tablet for breast cancer
  • Lapatinib 250mg for HER2-positive breast cancer
  • HER2-positive breast cancer medicine supplier
  • Anti-cancer medicine exporter from Nagpur India
  • Oncology medicine exporter from Nagpur
  • Pharmaceutical exporter from Nagpur India
  • Etibo 250mg Tablet export supplier
  • Etibo 250mg Tablet B2B supplier
  • Etibo 250mg Tablet global pharmaceutical supplier
  • Etibo 250mg Tablet supplier to USA
  • Etibo 250mg Tablet supplier to UK
  • Etibo 250mg Tablet supplier to Australia
  • Etibo 250mg Tablet supplier to Canada
  • Etibo 250mg Tablet supplier to Singapore
  • Etibo 250mg Tablet supplier to South Korea
  • Etibo 250mg Tablet supplier to UAE
  • Lapatinib 250mg wholesale pharmaceutical supplier
  • HER2 targeted therapy medicine exporter
  • Breast cancer oncology medicine exporter
  • Prescription oncology medicine supplier India
Aug 17th, 2026 3:27 PM

Keywords